Citation Impact
Citing Papers
Physical Activity and Public Health
2007 Standout
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
2013 Standout
Prospective study of endogenous tissue plasminogen activator and risk of stroke
1994
Sleep and Stroke
2009
Mechanisms of Thrombus Formation
2008 Standout
Microglia: active sensor and versatile effector cells in the normal and pathologic brain
2007 Standout
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Reactive microgliosis
1999
Five-Year Intra-Individual Variability in C-Reactive Protein Levels in a Japanese Population-Based Study
2000
Mammalian Notch1 Is Modified with Two Unusual Forms ofO-Linked Glycosylation Found on Epidermal Growth Factor-like Modules
2000
Analytical and Biologic Variability in Measures of Hemostasis, Fibrinolysis, and Inflammation: Assessment and Implications for Epidemiology
1999
Hydrogels in Regenerative Medicine
2009 Standout
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Correlations between fibrinolytic function and acute myocardial infarction
1990
Toward the quiescent coronary plaque
1993
Natural–origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications
2007
Interleukin‐13 and ‐4 induce death of activated microglia
2002
Hemostatic and inflammatory markers in obese youths: Effects of exercise and adiposity
2002
Prodrug Strategies in Anticancer Chemotherapy
2007
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Physiology and immunology of the cholinergic antiinflammatory pathway
2007 Standout
Exercise Standards for Testing and Training
2013 Standout
Using Pedometers to Increase Physical Activity and Improve Health
2007 Standout
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Physical Exertion as a Trigger of Acute Myocardial Infarction
1993
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
1995 Standout
Relationship between plasma plasminogen activator inhibitor 1 and insulin resistance
2000
Improved biochemical strategies for targeted delivery of taxoids
2007
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
2002 Standout
Coordinated Transcription of Key Pathways in the Mouse by the Circadian Clock
2002 Standout
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
2009 Standout
Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men
1995 Standout
Biomedical applications of biodegradable polymers
2011 Standout
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
2006 Standout
Evidence for prescribing exercise as therapy in chronic disease
2006
Platelet Activation and Atherothrombosis
2007 Standout
Day–Night Pattern of Sudden Death in Obstructive Sleep Apnea
2005
The contribution of thrombosis to the clinical expression of coronary atherosclerosis
1996
PAI‐1 and atherothrombosis
2005
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
2004 Standout
Serum C-reactive protein and fibrinogen concentrations and self-reported angina pectoris and myocardial infarction
2000
Circadian Variation of Fibrinolytic Activity in Blood
1991
Secondary prevention with folic acid: effects on clinical outcomes
2003
C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors
2000
Acute hyperglycemia and acute hyperinsulinemia decrease plasma fibrinolytic activity and increase plasminogen activator inhibitor type 1 in the rat
2001
Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk
2004
Triggering and hourly variation of onset of arterial thrombosis
1992
Protease-Activated Drug Development
2012
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain
2005 StandoutNature
Task Force II: Blood pressure measurement and cardiovacular outcome
2001
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
1994 Standout
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
Exercise characteristics and the blood pressure response to dynamic physical training
2001
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Refinement of the Association of Serum C-reactive Protein Concentration and Coronary Heart Disease Risk by Correction for Within-Subject Variation over Time: The MONICA Augsburg Studies, 1984 and 1987
2003
Early coronary reperfusion blunts the procoagulant response of plasminogen activator inhibitor-1 and von Willebrand factor in acute myocardial infarction
1990
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
1998 StandoutNature
Aerobic Exercise and Lipids and Lipoproteins in Women: A Meta-Analysis of Randomized Controlled Trials
2004
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Markers of Inflammation and Cardiovascular Disease
2003 Standout
PAI-1 and the Metabolic Syndrome
2006
Effects of Lipid-Lowering by Simvastatin on Human Atherosclerotic Lesions
2001 Standout
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
2009 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Extent of regression dilution for established and novel coronary risk factors: results from the British Regional Heart Study
2004
Exercise and its role in the prevention and rehabilitation of cardiovascular disease
1997
Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention
2003 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians.
1990
Part 9: Post–Cardiac Arrest Care
2010 Standout
Sudden cardiac death. Support for a role of triggering in causation.
1993
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
2006 Standout
Myosin Light Chain Kinase Functions Downstream of Ras/ERK to Promote Migration of Urokinase-Type Plasminogen Activator-Stimulated Cells in an Integrin-Selective Manner
1999
Variability and Classification Accuracy of Serial High-Sensitivity C-Reactive Protein Measurements in Healthy Adults
2001
Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells
2000 Standout
Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease.
1993
Ca2+Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase
2003 Standout
Coronary Plaque Disruption
1995 Standout
Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease
2003 Standout
C-Reactive Protein as a Cardiovascular Risk Factor
1999
Serum C-Reactive Protein and Self-Reported Stroke
2000
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
2001 Standout
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Cerebral Microvessel Responses to Focal Ischemia
2003
Exercise as Cardiovascular Therapy
1999
Increased Particulate Air Pollution and the Triggering of Myocardial Infarction
2001 Standout
Physiology of Microglia
2011 Standout
Recommendations for Blood Pressure Measurement in Humans and Experimental Animals
2005 Standout
Molecular Bases of the Acute Coronary Syndromes
1995 Standout
Endothelial Function and Dysfunction
2007 Standout
Works of A.C.W. de Bart being referenced
Mitogenic Effects of Urokinase on Melanoma Cells Are Independent of High Affinity Binding to the Urokinase Receptor
1998
Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke
1988
Biochemical and functional modulation of the cartilage collagen network by IGF1, TGFβ2 and FGF2
2006
Effect of propranolol (long-acting) on the circadian fluctuation of tissue-plasminogen activator and plasminogen activator inhibitor-1
1991
Plasminogen activator and matrix metalloproteinase production and extracellular matrix degradation by rat prostate cancer cells in vitro: Correlation with metastatic behavior in vivo
1997
Role of astrocyte-derived tissue-type plasminogen activator in the regulation of endotoxin-stimulated nitric oxide production by microglial cells
1998
Circadian patterns of plasma t-PA and PAI-1 antigen levels in patients with severe peripheral atherosclerosis
1996
Contribution of collagen network features to functional properties of engineered cartilage
2007
Synthesis and Biological Evaluation of Novel Prodrugs of Anthracyclines for Selective Activation by the Tumor-Associated Protease Plasmin
1999
Variability in information from a single venapuncture in healthy volunteers: Analysis of the haemostatic variables fibrinogen, Plasminogen Activator Inhibitor (PAI) activity and histidine-rich glycoprotein (HRG)
1992
Acute exogenous hyperinsulinaemia does not result in elevation of plasma plasminogen activator inhibitor-1 (PAI-1) in humans
1990
Interindividual and Intraindividual Variability in Plasma Fibrinogen, TPA Antigen, PAI Activity, and CRP in Healthy, Young Volunteers and Patients With Angina Pectoris
1996
Effects of exercise training on plasminogen activator inhibitor activity
1992
Short term extreme increases in plasminogen activator inhibitor 1 (PAI-1) in plasma of polytrauma patients
1988